Foldax Inc.
PrivateLast Round
Series D
Jun 22, 2020
Total Funding Raised
$20M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Foldax Inc. is a medical device company focused on reinventing heart valves to create treatments that can last a lifetime. The company develops synthetic, biopolymer heart valves (the TRIA platform) designed to address the historical trade-offs between traditional tissue and mechanical valves. Its proprietary LifePolymer material is intended to be more durable and reduce the risk of calcification, potentially eliminating the need for lifelong anticoagulant medication for patients. Foldax utilizes robotic manufacturing to ensure precision, consistency, and quality, which also improves the economics of production. The company is conducting clinical trials for its aortic and mitral valves and has received approval for commercial use of its TRIA mitral valve in India.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials, Clinical Trials, Smart Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Foldax Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Foldax Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jun 22, 2020 | ||||
| VC Round | Dec 19, 2018 | ||||
| Series A | Aug 31, 2015 |
Foldax Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Summation Health Ventures | VC Round |
| California Institute of Technology Investment Office | Series D, VC Round |
| Kairos Ventures | Series D, VC Round, Series A |
| BioStar Capital | Series D, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 77% MoM.
- Sep 5, 2025
Partnered with Dolphin Life Science LLP for India launch.
Foldax Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Foldax Inc.'s valuation, stock price, and market status.